Dr. Hiren Patel is a Professor in the Department of Electrical and Computer Engineering at the University of Waterloo. He holds a Doctorate in Computer Engineering from Virginia Tech and previously worked as a postdoctoral fellow at UC Berkeley under Edward A. Lee. His research focuses on real-time embedded systems, computer architecture, machine learning hardware, and cybersecurity. He teaches courses like ECE 150 (Programming), ECE 320/429 (Computer Architecture), and ECE 327 (Digital Systems). Research Interests: Cyber-physical systems and hybrid architectures Hardware/software co-design methodologies Predictable cache coherence protocols IoT and edge computing systems Security in embedded and real-time systems Recent work emphasizes cache coherence solutions for safety-critical systems and GPU acceleration strategies. His publications address challenges in multicore predictability, FPGA bandwidth optimization, and autonomous robotics orchestration. No specific awards are listed, though his extensive publication record indicates significant contributions to embedded systems research. He currently oversees graduate student applications focusing on his core research areas.
Rotem Karni, PhD, is an Associate Professor of Genetics at the Perelman School of Medicine, University of Pennsylvania, Philadelphia. He leads a research lab focused on understanding how alternative RNA splicing contributes to cancer and genetic diseases, with a strong emphasis on translating these findings into RNA-based therapies. Karni's lab develops decoy oligonucleotides, small molecules, and splice-switching technologies to modulate splicing factors and enhance immunotherapy. Education BSc in Biological Chemistry from The Hebrew University of Jerusalem (1997) PhD in Biological Chemistry from The Hebrew University of Jerusalem, Israel (2002) Postdoctoral Fellowship at Cold Spring Harbor Laboratory, NY (2002-2007) Karni's research explores the deregulation of alternative splicing in oncogenesis, particularly how splicing factors like RBFOX2 and S6K1 influence metastasis, DNA repair, and immune checkpoint modulation. His team investigates m6A RNA modifications for stabilizing mutant genes, with applications in Duchenne Muscular Dystrophy and pancreatic cancer. The lab's work is commercialized through biotech companies: SKIP Therapeutics, Andlit Therapeutics, and RNAble. Selected Research Trends RNA mis-splicing and neoantigen generation (2025) Splicing factor inhibition for tumor suppression (2023) Metastatic splicing signatures in pancreatic cancer (2023) Immune checkpoint splicing in cancer immunotherapy (2021) m6A modulation for mRNA stabilization (2023) Advising & Collaborations Karni has mentored numerous PhD and postdoctoral researchers, many of whom now hold leadership roles in academia, biotech, and medical institutions globally. His lab collaborates extensively on projects involving RNA innovation, including partnerships with the Institute for RNA Innovation. Contact Department of Genetics & Institute for RNA Innovation, One uCity Square, Room 4018, Philadelphia, PA 19104 Phone: 215-898-5072 Email: Rotem.Karni@Upenn.edu
Andrew R. Meyer is an Associate Professor in the Department of Health, Human Performance, and Recreation at Baylor University, where he teaches courses in Sport Psychology and Religion and Sport. His academic work bridges the fields of sport sociology, cultural studies, and theology, with a particular focus on the enduring influence of muscular Christianity in American sports. His research interests include: Contemporary American Sport Culture and Religion Muscular Christianity and its modern manifestations Hero-celebrity athletes in popular culture Character development through sport and education Traditional and contemporary Indigenous sport cultures Sport's cultural impact on communities The themes across his publications reveal a consistent exploration of the moral, spiritual, and cultural dimensions of sport. His work analyzes how religious values, particularly those rooted in Christian traditions, shape athlete identity, media narratives, and public perception of sports figures. He has developed the Contemporary Muscular Christian Instrument (2017, 2020) to measure these values across global sport contexts. His articles appear in interdisciplinary journals spanning religion, sociology, public health, and cultural studies, reflecting the broad relevance of his research. Scientific awards and recognitions include: Baylor Teaching Fellow (2017) Dr. Meyer has been active in academic and public discourse, serving as a keynote speaker at international conferences on sport and Christianity and being featured on media outlets such as NPR and the Sport, Faith, Life podcast. His teaching emphasizes character formation in the classroom, aligning with his research on moral development through sport. While specific grant funding is not mentioned, his extensive publication record in peer-reviewed journals and edited volumes indicates sustained scholarly productivity. He has contributed to discussions on mega-sport events, cycling culture, and the redemption narratives of fallen athletes like Lance Armstrong. He is affiliated with the College of Health, Human Performance, and Recreation at Baylor University, contributing to both graduate and undergraduate education in sport studies.
Carme Torras Genís is a Research Professor at the Spanish National Research Council (CSIC), affiliated with the Institute of Robotics and Industrial Informatics (IRI) in Barcelona and the Technical University of Catalonia (UPC). Her career spans over three decades, focusing on robotics, neurocomputing, and artificial intelligence with applications in healthcare and deformable object manipulation. M.Sc. in Mathematics (University of Barcelona, 1978) M.Sc. in Computer Science (University of Massachusetts, 11981) Ph.D. in Computer Science (UPC, 1984) Research Interests : Robotic manipulation of deformable objects (especially textiles) Neurocomputing and machine learning for robotic control Human-robot interaction and assistive robotics Computational topology for cloth state representation Ethics in social robotics and AI Medical applications of robotics for neuromuscular disease assessment Scientific Leadership : ERC Advanced Grant recipient (2016) IEEE and EurAI Fellow Coordinator of Horizon Europe project SoftEnable and former ERC project CLOTHILDE Editorial leadership in IEEE Transactions on Robotics and multiple journals Active in ethics committees and AI policy advisory boards Advisory Committee of Ethics in AI (Catalan Government) Vice-President of CSIC Ethics Committee Member of Royal Academy of Engineering (Spain)
Christopher E. Nelson is an Assistant Professor in the Department of Biomedical Engineering at the University of Arkansas, College of Engineering. His lab focuses on developing biologically inspired strategies for controlled drug and gene delivery, particularly in the context of gene therapy and regenerative medicine. He is actively supported by the NIH, DoD, and Arkansas Bioscience Institute. Education: Postdoctoral Fellow – Duke University Ph.D. – Vanderbilt University B.S. – University of Arkansas Research Focus: Dr. Nelson’s lab integrates genome editing technologies with targeted delivery systems to address challenges in treating genetic diseases and promoting tissue regeneration. Major themes include CRISPR/Cas9 delivery , gene regulation in wound healing , and safe-harbor genome integration in skeletal muscle. His work spans viral and non-viral delivery vehicles , including lipid nanoparticles and AAV vectors, with a strong emphasis on preclinical validation in models of Duchenne muscular dystrophy and inflammatory disease. Scientific Awards: Controlled Release Society Postdoctoral Fellowship The Hartwell Foundation Postdoctoral Fellowship NIH Pathway to Independence Award (K99/R00) Funding & Support: The Nelson Lab is currently funded by: NIH NIGMS R35 DoD CDMRP DMD IDEA Award Arkansas Bioscience Institute University of Arkansas Engineering & Honors Colleges Lab & Team: The Nelson Lab is a dynamic, interdisciplinary team working at the intersection of gene editing, biomaterials, and regenerative medicine. They regularly present at national conferences such as ASGCT and NCUR, and mentor undergraduate researchers through SURF and Honors College grants.
Foteini Mourkioti is an Associate Professor at the University of Pennsylvania's Perelman School of Medicine , with a joint appointment in the Graduate Groups of Cell and Molecular Biology and Bioengineering . She co-directs the Musculoskeletal Regeneration Program at the Penn Institute of Regenerative Medicine and leads the McKay Orthopaedic Research Laboratory . Research Interests : Muscle Stem Cell Biology Mechanobiology Muscle Regeneration Telomere Biology in Muscular Diseases Fibrodysplasia Ossificans Progressiva (FOP) Cardiomyopathy and Aging Key Research Contributions : Developed the Pax7EGFP mouse model for real-time muscle stem cell tracking Discovered telomere shortening as a critical factor in Duchenne Muscular Dystrophy Elucidated the role of NF-κB in muscle stem cell dysfunction Identified Piezo1's role in stem cell morphological states Characterized fibro-adipogenic progenitor dynamics in FOP Scientific Awards : NIH/NHLBI R01 grant recipient (2019) NASA grant awardee (2020, 2017) American Heart Association grant (2017) Muscular Dystrophy Association grant (2019) University Research Foundation grant (2018) Publications & Collaborations : Over 25 publications in high-impact journals like Science Advances , Nature Protocols , and Cell Reports . Collaborates with Penn Cardiovascular Institute and Pennsylvania Muscle Institute.
Dr. Peter L. Latchman serves as a Professor in the Department of Health and Movement Sciences at Southern Connecticut State University. He holds a Doctorate in Applied Physiology from Columbia University and is an Overseas Fellow of the Royal Society of Medicine. His academic career spans decades of research in autonomic cardiovascular regulation with applications to diverse populations including Young adults post-COVID-19 infection Ethnic disparities in baroreflex sensitivity Autonomic dysfunction in obese children Central hemodynamic analysis Recent scholarship focuses on autonomic modulation patterns and their implications for cardiovascular health, while his teaching portfolio encompasses both graduate and undergraduate courses in exercise physiology, cardiac rehabilitation, and medical terminology. Dr. Latchman has delivered presentations at international symposia on topics including Baroreflex sensitivity in African American populations Effects of aerobic capacity on autonomic recovery Vascular physiological assessment techniques Scientific contributions include Overseas Fellowship, Royal Society of Medicine $10,000 grant for cardiovascular assessment in autistic children (2023) He maintains active research collaborations with institutions such as East China Normal University and Hong Kong Baptist University.
Dr. Ian Wilson is a researcher at Newcastle University with a focus on medical genetics, nephrology, and genomic analysis. His work spans genetic determinants of kidney diseases, mitochondrial disorders, and biomarker development. Notable contributions include studies on uromodulin genetics in African populations, copy-number variations in rare diseases, and kidney ciliopathies. He has collaborated extensively on projects involving genome sequencing, mitochondrial replacement therapy, and muscular dystrophy biomarkers. Wilson's research integrates computational tools like machine learning for predictive modeling in urolithiasis and employs advanced imaging techniques for disease progression monitoring. Key areas: Genetic epidemiology, renal genomics, mitochondrial DNA analysis Focus on translational applications: Biomarker development for kidney stones and muscular dystrophies Interdisciplinary collaborations in ophthalmology and orthopedics His publications reflect a commitment to advancing diagnostic accuracy and understanding complex genetic disorders through multi-omics approaches.
Theresa Raimondo is the Manning Assistant Professor of Engineering at Brown University, with a secondary appointment in the Division of Biology and Medicine. She joined the Brown Engineering faculty in January 2024 after completing her postdoctoral training at MIT's Koch Institute. Dr. Raimondo leads the Raimondo Research Lab, which focuses on chemically modifying RNA and designing nanoparticles for therapeutic delivery to the body, an immunotherapy concept that holds immense promise in the field of immunoengineering. Her educational background includes: PhD in Engineering Sciences – Bioengineering from Harvard University (2019) MEng from Harvard University (2019) Sc.B. in Chemical and Biochemical Engineering from Brown University (2011) Dr. Raimondo's research is broadly focused on the design of targeted drug-delivery vectors and novel RNA-based therapeutics for applications in cancer, immunotherapy, and tissue regeneration. Her work primarily centers on developing novel lipid nanoparticles (LNPs) for RNA-based therapies, contributing to adjuvanted mRNA-based vaccines and siRNA-based cancer immunotherapies. By optimizing LNP formulation and modulating RNA constructs, she seeks to understand how RNA-LNPs modulate immunity and develop new therapeutic approaches. Her expertise spans biomaterials, drug delivery, biomolecular engineering, nanomedicine, tissue engineering, and regenerative medicine. Analysis of Dr. Raimondo's recent publications reveals a strong focus on RNA delivery systems and lipid nanoparticle technology. Her work spans from fundamental studies on nanoparticle design to applications in cancer immunotherapy, vaccine development, and tissue regeneration. A significant portion of her research involves optimizing lipid formulations for improved mRNA delivery and exploring how these systems interact with the immune system. Her publications demonstrate a trajectory from basic biomaterials research to increasingly translational work with therapeutic applications. Dr. Raimondo has received numerous prestigious awards: 2025 NAE Symposium selection (Grainger Foundation Frontiers of Engineering) 2025 appointment to the inaugural Early Career Board of ACS Applied Bio Materials 2024 selection as MIT Faculty Founder Initiative finalist 2022 Convergence Scholar fellowship from MIT's Marble Center for Cancer Nanomedicine National Science Foundation graduate research fellowship Harvard's Smith family graduate fellowship Dr. Raimondo is actively involved in mentoring students through courses including ENGN 0931L - Biomedical Engineering Design and Innovation II, ENGN 1490 - Biomaterials, and ENGN 1931L - Biomedical Engineering Design and Innovation II. Her research program is supported by various grants, though specific funding sources aren't detailed in the provided text. The Raimondo Research Lab represents a dynamic environment where engineering principles are applied to solve complex biological challenges in drug delivery and regenerative medicine. The Raimondo Research Lab at Brown University serves as a hub for innovation in RNA delivery and biomaterials design. The lab brings together expertise in chemical engineering, molecular biology, and immunology to develop next-generation therapeutic platforms. Current research directions include optimizing lipid nanoparticle formulations, exploring novel RNA modifications, and investigating immune responses to RNA therapeutics across various disease contexts.
Pablo Perez-Pinera is an Associate Professor in Biomedical and Translational Sciences at the Carle Illinois College of Medicine, University of Illinois. He leads the Genome Engineering and Transcriptional Regulation Laboratory, focusing on developing gene editing technologies for treating neurodegenerative and neuromuscular diseases. His research integrates cutting-edge genome engineering tools with innovative delivery systems to address previously incurable conditions. Dr. Perez-Pinera's research interests center on developing CRISPR-based genome editing technologies for therapeutic applications. His laboratory specializes in base editing approaches for exon skipping, particularly targeting diseases like Duchenne muscular dystrophy, Huntington's disease, Parkinson's disease, Alzheimer's disease, and ALS. His team develops novel delivery systems using AAV vectors to enable precise in vivo genome editing, with a particular focus on neurological and muscular disorders. The lab's work bridges fundamental molecular biology with translational applications, aiming to move promising technologies from bench to bedside. His laboratory has made significant contributions to the field of therapeutic genome editing, particularly in developing the SPLICER platform for efficient exon skipping through simultaneous splice site editing. His publications demonstrate expertise in base editing for neurodegenerative diseases, with multiple first-author and corresponding author papers in high-impact journals. His research has been supported by several NIH grants including R01 GM131272, UL1 TR001422, R01 GM141296, among others. Dr. Perez-Pinera actively mentors a diverse team of researchers including postdoctoral fellows, graduate students, and undergraduates. His laboratory includes researchers such as Devyani Swami (Postdoctoral Fellow), Michael Gapinske, Jackson Winter, Shraddha Shirguppe, Angelo Miskalis, and others who contribute to various aspects of genome engineering research. His grant funding supports both basic research on genome editing mechanisms and translational work toward therapeutic applications. The Genome Engineering and Transcriptional Regulation Laboratory maintains state-of-the-art facilities for molecular biology, cell culture, and in vivo studies. The team collaborates extensively with clinicians and researchers across the University of Illinois campus to translate genome editing discoveries into potential therapies for patients suffering from neurodegenerative and neuromuscular conditions.
Patrick J. Cahill, MD, is a pediatric spine specialist and the Robert M. Campbell Jr. Endowed Chair in Thoracic Insufficiency Syndrome at Children's Hospital of Philadelphia (CHOP). His clinical expertise spans disorders of the pediatric spine, scoliosis, cervical spine conditions, and minimally invasive surgical techniques. He leads the Center for Thoracic Insufficiency Syndrome, collaborating with pulmonology, anesthesia, and physical therapy teams. Academic Role: Physician Scientist Leadership: Director of the Center for Thoracic Insufficiency Syndrome Research Focus: Spinal growth modulation, 3D surgical planning, and reducing anesthesia exposure in young patients His work emphasizes fusionless treatments like magnetically expandable growing rods and Mehta casting, alongside innovations in dynamic MRI for preoperative assessment. Recent publications highlight comparative studies on spinal fusion techniques, surgical complication classifications, and multidisciplinary approaches to complex cases. Awards: Philadelphia Magazine's Top Doctors (2022), SRS Travelling Fellowship (2015) Professional Memberships: Scoliosis Research Society, North American Spine Society, Pediatric Orthopaedic Society of North America
Prof. Casper Hoogenraad is a full professor in Molecular Neuroscience at the Department of Cell Biology, Faculty of Science, Utrecht University. His research focuses on understanding how intracellular protein trafficking underlies neuronal development and function, with particular emphasis on the microtubule cytoskeleton, synaptic cargo trafficking, and synaptic plasticity. He leads an active research group within Utrecht University's Cell Biology department and collaborates extensively with other neuroscience research groups. Education: PhD, Erasmus University Rotterdam (1996-2001) Postdoc, Massachusetts Institute of Technology (2002-2005) Hoogenraad's research spans three main themes: cytoskeleton dynamics during neurodevelopment and synaptic plasticity, motor proteins and adaptors as regulators of synaptic transport, and psychiatric and neurologic disease disorders linked to intracellular transport. His work combines genetics, biochemistry, molecular, and cellular biology methods in in vitro (neuron cultures), ex vivo (brain slices), and in vivo (mice) systems, along with advanced microscopy techniques including immunofluorescent confocal microscopy, high-resolution live cell imaging, and photo-activated localization microscopy (PALM). Analysis of Hoogenraad's recent publications reveals a strong focus on microtubule organization, neuronal polarity, and the molecular mechanisms underlying synaptic function and dysfunction. His work frequently explores how disruptions in intracellular transport contribute to neurological disorders including Alzheimer's disease, schizophrenia, and autism spectrum disorders, with particular attention to the relationship between cytoskeletal organization and cargo transport in neuronal compartments. Scientific Awards and Memberships: ZonMW-VIDI (2004) European Young Investigators (EURYI) award (2005) NWO-ALW VICI (2011) ERC Consolidator grants (2013) FENS-Kavli Network of Excellence (2014) European Molecular Biology Organization (EMBO) (2015) Young Academy of Europe (YAE) (2015) IBRO Kemali Prize (2016) Hoogenraad leads a research group studying neuronal development and function, with a particular focus on how intracellular transport mechanisms contribute to both normal brain function and neurological disorders. His laboratory employs a multidisciplinary approach combining molecular, cellular, and systems neuroscience techniques to investigate the molecular basis of neuronal polarity, synaptic plasticity, and the pathogenesis of neurological disorders. He has secured significant research funding through prestigious grants including ERC Consolidator grants. The Hoogenraad lab operates within the Cell Biology department at Utrecht University, collaborating with other research groups focusing on cellular dynamics, biophysics, and neurobiology. The lab utilizes advanced microscopy techniques including immunofluorescent confocal microscopy, high-resolution live cell imaging (spinning disc microscopy and total internal reflection fluorescence microscopy), and quantitative analysis using advanced high-resolution microscopy (photo-activated localization microscopy). Current lab technicians include Phebe Wulf and Bart de Haan.
Zhi-Pei Liang is the Franklin W. Woeltge Professor in the Department of Electrical and Computer Engineering at the University of Illinois at Urbana-Champaign, with joint appointments in the Department of Bioengineering, Beckman Institute for Advanced Science and Technology, and Coordinated Science Laboratory. His research spans biomedical engineering, medical imaging, and signal processing with a focus on advancing magnetic resonance imaging and spectroscopy technologies. His educational background includes a Ph.D. in Biomedical Engineering from Case Western Reserve University (1989) and a B.S. in Electrical Engineering from South-China University of Technology (1982), followed by postdoctoral training at UIUC (1989-1991). Professor Liang's research interests center on magnetic resonance imaging and spectroscopy , with particular emphasis on ultrafast imaging techniques , model-based reconstruction methods , and the integration of physics-based modeling with machine learning . His pioneering work on SPICE (SPectroscopic Imaging by exploiting spatiospectral CorrElation) has revolutionized high-resolution metabolic brain imaging by enabling label-free molecular imaging through the marriage of spin physics and machine learning. His research spans pattern recognition, parameter estimation, image formation theory, and algorithms for medical imaging applications. Analysis of his recent publications reveals a strong focus on high-resolution metabolic imaging , particularly using SPICE methodology to map brain metabolism with unprecedented detail. His work bridges fundamental physics of magnetic resonance with advanced computational methods to overcome traditional limitations in imaging speed and resolution. Current research directions include J-resolved spectroscopic imaging, deuterium-based metabolic mapping, and multimodal integration of PET and MRSI for studying neurological disorders. Elected to International Academy of Medical and Biological Engineering (2012) Gold Medal, International Society for Magnetic Resonance in Medicine (2022) Technical Achievement Award, IEEE Engineering in Medicine and Biology Society (2014) Fellow, National Academy of Inventors (2021) Author of influential book 'Principles of Magnetic Resonance Imaging' (1999) President of IEEE Engineering in Medicine and Biology Society (2011-2012) Professor Liang has advised numerous students and postdocs in biomedical imaging research and has received multiple teaching honors including the Ronald W. Pratt Outstanding Teaching Award (2005) and multiple listings among UIUC's Excellent Teachers. His research has been supported by various grants from NIH, NSF, and other funding agencies. He leads the SPICE (Spectroscopic Imaging by exploiting spatiospectral Correlation) research group which focuses on developing novel imaging techniques that combine physics-based modeling with machine learning for ultrafast metabolic imaging. His laboratory, part of the Beckman Institute's Integrative Imaging Theme, collaborates extensively with clinical researchers at Carle Illinois College of Medicine and other institutions to translate advanced imaging techniques into clinical applications for neurological disorders, cancer, and metabolic diseases. Current projects focus on high-resolution mapping of brain metabolism in Alzheimer's disease, stroke, and brain tumors using novel MR spectroscopic imaging techniques.
Dr. Bradley Schoenfeld is a Professor of Exercise Science at Lehman College, serving as Graduate Director of the Human Performance and Fitness program. He previously acted as Sports Nutritionist for the New Jersey Devils hockey team. His research focuses on the effects of exercise on body composition, particularly muscle hypertrophy and fat loss, along with related nutrition interventions. Schoenfeld has authored over 300 peer-reviewed papers and the influential textbook Science and Development of Muscle Hypertrophy . He has received notable awards including the 2016 Dwight D. Eisenhower Fitness Award and 2018 NSCA Young Investigator of the Year. His work examines muscular adaptations from exercise variables manipulation, body composition changes, and supplementation effects. Key research themes include resistance training protocols, load progression strategies, and the physiological mechanisms underlying muscle growth. Education: Doctoral degree in Exercise Science Key Affiliations: National Strength and Conditioning Association (NSCA Fellow) Publications consistently address practical applications of resistance training science, emphasizing evidence-based approaches to optimize muscle development. His studies frequently explore training variables like volume, frequency, intensity, and rest periods. Grants and collaborations have supported investigations into deload strategies, isometric training effects, and nutritional strategies for hypertrophy. Labs/Teams: Conducts research through Lehman College's Human Performance Lab Future Work: Continuing exploration of training variables optimization and nutritional ergogenic aids
Mahipal Singh is a Professor of Animal Biotechnology and Coordinator of the Animal Science Undergraduate Program at Fort Valley State University (FVSU), where he is affiliated with the College of Agriculture, Family Sciences and Technology and the Department of Agricultural Sciences. He has been at FVSU since 2000 in various capacities, progressing from Adjunct Biology/MPH Graduate Faculty to his current position as full Professor since 2019. Dr. Singh earned his educational credentials in India: a B.S. (Hons) in Zoology from Meerut College (1978), an M.S. in Zoology from the Institute of Advanced Studies, Meerut University (1983), and a Ph.D. in Zoology-Microbiology from Banaras Hindu University, Varanasi (1989). His academic journey included prestigious appointments such as International Visiting Fellow at the National Institute of Child Health and Human Development, NIH (1991-1993) and Postdoctoral Fellow at the Medical University of South Carolina (1989-1991). His research focuses on cutting-edge areas of animal biotechnology, particularly in postmortem cell recovery, genome editing in livestock, and myostatin gene targeting. Dr. Singh has pioneered work demonstrating that individual cells remain viable in mammalian tissues for much longer periods after death than previously believed, with applications for cellular therapies and germplasm preservation. His work with CRISPR/Cas technology aims to reduce milk allergens and mastitis in goats, while his myostatin research seeks to enhance muscular mass in meat goats for agricultural applications. Analysis of his recent publications reveals a consistent focus on cellular viability after death across multiple livestock species (cattle, goats, sheep), with particular attention to temperature effects and storage conditions. His work bridges basic cellular biology with practical agricultural applications, demonstrating how fundamental discoveries about postmortem cellular life can translate into biotechnological advances for livestock preservation and improvement. USDA-ARS 1890 Faculty Research Fellowship Award (2017) STEM Research Excellence Award, Fort Valley State University (2014-15) Multiple student research presentation awards at FVSU Annual Research Day symposiums Best Poster Award at National Symposium on Biotechnology, CIMAP, Lucknow, India (1999) Fogarty International Visiting Fellowship at NIH (1991-93) Dr. Singh has supervised an impressive 38 students across multiple educational levels, including 4 PhD, 13 MS, 7 BS, 8 HS, and 6 middle school students. His research has been supported by USDA-ARS, USDA-NIFA programs, and various other grants. He serves on multiple editorial boards, grant review panels, and university committees, and is an active member of professional societies including the American Society of Animal Science and Society for In Vitro Biology. Based in the Stallworth Biotechnology Building at FVSU, Dr. Singh leads research projects that bridge molecular biology with practical agricultural applications, working collaboratively with researchers from USDA-ARS, University of Illinois, University of Maryland, and other institutions to advance animal biotechnology and improve livestock production systems.
